SCHEDULE 13G/A: Vivo Capital IX, LLC Discloses Passive 4.5% Stake in Sera Prognostics, Inc.
Beneficial Ownership Report
Vivo Capital IX, LLC has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 4.5% of Sera Prognostics, Inc.'s Class A common stock.
Summary
- Vivo Capital IX, LLC, a Delaware limited liability company, has filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Sera Prognostics, Inc.
- The filing indicates that Vivo Capital IX, LLC beneficially owns 1,650,440 shares of Sera Prognostics, Inc.'s Class A common stock.
- This ownership represents 4.5% of the Class A common stock outstanding.
- The percentage is calculated based on 36,705,025 shares of Class A common stock outstanding as of May 2, 2025, as disclosed in Sera Prognostics, Inc.'s Quarterly Report on Form 10-Q filed on May 7, 2025.
- Vivo Capital IX, LLC, as the general partner of Vivo Capital Fund IX, L.P., holds sole voting and sole dispositive power over all 1,650,440 shares.
- The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing disclosing passive ownership. It is neutral in tone, with the presence of an institutional investor being a minor positive signal without implying active involvement or significant new developments.
Positives
- The disclosure provides transparency regarding significant institutional ownership in Sera Prognostics, Inc.
- The continued holding of a stake by an institutional investor like Vivo Capital IX, LLC can be viewed as a vote of confidence in the company, even if passive.
Negatives
- No specific negative financial or operational details are disclosed in this ownership report.
Risks
- This document does not detail specific risks related to Sera Prognostics, Inc.'s operations or financial health, as it is an ownership disclosure.
Future Outlook
This Schedule 13G filing does not contain any forward-looking statements or guidance regarding the issuer's future outlook.
Industry Context
This filing is a routine disclosure of an institutional investor's passive stake in a publicly traded company. It does not provide broader industry trends or competitive analysis for the prognostics sector.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership and confirms the passive nature of this stake.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement. |
| 05/02/2025 | Date as of which 36,705,025 shares of Class A common stock were outstanding, as disclosed by the Issuer. |
| 05/07/2025 | Date Sera Prognostics, Inc. filed its Quarterly Report on Form 10-Q, disclosing shares outstanding. |
| 05/14/2025 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
Sera Prognostics, Vivo Capital, Schedule 13G, beneficial ownership, Class A common stock, SEC filing, institutional investor, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.